Parexel International Corp - Strategic SWOT Analysis Review

December 2021 | 42 pages | ID: PEAC8A6F5F4EN
GlobalData

Abstracts

Parexel International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Parexel International Corp (Parexel), a subsidiary of Pamplona Capital Management LLP is a biopharmaceutical outsourcing service company. It provides services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Newton, Massachusetts, the US.

Parexel International Corp Key Recent Developments

Aug 02,2021: Parexel’s Peyton Howell and Sofia Baig named to 2021 PharmaVOICE 100
Jul 22,2021: Parexel announces innovative partnership with Rare Disease Foundation in China
Jul 07,2021: Parexel Expands Asia/Pacific capability through enhanced clinical trial supplies and logistics offering
Jul 05,2021: EQT and Goldman Sachs to acquire Parexel for $8.5bn
May 04,2021: Parexel achieves top rankings in industry across multiple attributes in ISR CRO phase II-III benchmarking report

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Parexel International Corp - Key Facts
Parexel International Corp - Key Employees
Parexel International Corp - Key Employee Biographies
Parexel International Corp - Major Products and Services
Parexel International Corp - History
Parexel International Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Parexel International Corp - Business Description
Parexel International Corp - SWOT Analysis
SWOT Analysis - Overview
Parexel International Corp - Strengths
Parexel International Corp - Weaknesses
Parexel International Corp - Opportunities
Parexel International Corp - Threats
Parexel International Corp - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Parexel International Corp, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Aug 02, 2021: Parexel’s Peyton Howell and Sofia Baig named to 2021 PharmaVOICE
Jul 22, 2021: Parexel announces innovative partnership with Rare Disease Foundation in China
Jul 07, 2021: Parexel Expands Asia/Pacific capability through enhanced clinical trial supplies and logistics offering
May 04, 2021: Parexel achieves top rankings in industry across multiple attributes in ISR CRO phase II-III benchmarking report
Apr 16, 2021: Parexel and Veeva Systems collaborate to advance clinical trial technology
Feb 04, 2021: Parexel and NeoGenomics announce strategic collaboration in precision medicine to improve study designs and accelerate patient matching in oncology clinical trials
Jan 13, 2021: Parexel and Signify Health collaborating to develop new solutions to promote access and inclusion in clinical trials
Jan 11, 2021: Parexel completes separation of Parexel Informatics and Medical Imaging Business
Jan 04, 2021: Parexel names Clare Grace to newly-created role of Chief Patient Officer
Dec 14, 2020: Parexel joins Decentralized Trials & Research Alliance (DTRA) to enhance patient access, increase diversity and accelerate trial timelines

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Parexel International Corp, Key Facts
Parexel International Corp, Key Employees
Parexel International Corp, Key Employee Biographies
Parexel International Corp, Major Products and Services
Parexel International Corp, History
Parexel International Corp, Other Locations
Parexel International Corp, Subsidiaries
Parexel International Corp, Key Competitors
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Parexel International Corp, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021